Publications by authors named "Barry Reicher"

Claim this Profile
W
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials.
Kieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, Rudolf A DE Boer, Jersey Chen, Barry Reicher

J Card Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health-Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis.
Folke Folkvaljon, Morie Gertz, Julian D Gillmore, Sami Khella, Ahmad Masri, Barry Reicher

Muscle Nerve· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE Trials.
Kieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon, Rudolf A de Boer, Martin R Cowie, Barry Reicher

Circ Heart Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
John J V McMurray, Kieran F Docherty, Rudolf A de Boer, Ann Hammarstedt, Dalane W Kitzman, Barry Reicher

Circulation· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
Marat Fudim, Jennifer White, Neha J Pagidipati, Yuliya Lokhnygina, Julio Wainstein, Barry Reicher

Circulation· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.
Robert J Mentz, M Angelyn Bethel, Peter Merrill, Yuliya Lokhnygina, John B Buse, Barry Reicher

J Am Heart Assoc· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Totally endoscopic coronary artery bypass grafting is feasible in morbidly obese patients.
Atiq Rehman, Jose Garcia, Seema Deshpande, Patrick Odonkor, Barry Reicher

Heart Surg Forum· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques.
Robert S Poston, Richard Tran, Michael Collins, Marty Reynolds, Ingrid Connerney, Barry Reicher

Ann Surg· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes.
Barry Reicher, Robert S Poston, Mandeep R Mehra, Ashish Joshi, Patrick Odonkor

Am Heart J· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass.
Zachary N Kon, Emile N Brown, Richard Tran, Ashish Joshi, Barry Reicher

J Thorac Cardiovasc Surg· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hybrid alternative for high risk left main disease.
David Zimrin, Peter A Reyes, Barry Reicher, Robert S Poston

Catheter Cardiovasc Interv· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis